Parenteral Drugs (India) Ltd
Parenteral Drugs (India) Ltd Company History
Parenteral Drugs (India) Company engaged primarily in the business of Manufacturing of Pharmaceutical Product. The Company is also engaged in trading in various products.
2003
Parenteral Drug Board approves Delisting of shares from MP, Ahmedabad and Madras Stock Exchanges
2003
2004
Develops self-administering dialysis kit which reduces the cost of kidney failure treatment
PDPL sets up second sales unit in Kerala
2004
2007
The Company has issued Bonus Shares in the Ratio of 1:1.
2007
2008
Parenteral Drugs India Ltd has appointed Shri Anil Mittal as additional Director as well as whole time Director, subject to the approval of the members at the annual general meeting of the Company.
2008
2010
Parenteral Drugs India Ltd (PDIL) has entered into an exclusive license, supply and distribution agreement with M/s. Sinovac Biotech Co. Limited, China, through its subsidiary M/s Parenteral Biotech Ltd, in order to purchase and supply of HIN1 Influenza Vaccine (Split Virion) and Inactivated (PANFLU,1) for supply of the said products in the Indian market on an exclusive basis.
Parenteral Drugs (India) Ltd has given the Bonus in the Ratio of 1:3
2010
2013
Mr. Yogesh Khakre has been appointed as Company Secretary & Compliance Officer of the Company.
2013
2014
Punjab Formulations Limited, a wholly owned subsidiary Company has merged with Goa Formulations Limited.
Goa Formulations Limited has been changed from "Goa Formulations Limited" to "Infutec Healthcare Limited" w.e.f. October 31, 2014.
2014
2015
Parenteral Drugs India Ltd has commenced its production at the relocated plant situated at Village Panwa, Tehsil Kasrawad, District Khargone, Madhya Pradesh
2015
